Inventor · disambiguated record
Robert A. Zivin
Also filed as: ZIVIN ROBERT · ZIVIN ROBERT A · ZIVIN ROBERT ALLAN
11 granted patents·14 pending applications·1,317 citations·filing 1985–2012
93Inventor score
Top patents by PatentIndex Score
25 records- 0198US5929212ACD3 specific recombinant antibodyCELLTECH THERAPEUTICS LTD·Filed 1993·Granted Jul 27, 1999·298 cites·13 claims
- 0296US5885573AMethods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodiesARCH DEV CORP·Filed 1993·Granted Mar 23, 1999·400 cites·3 claims
- 0396US5767078AAgonist peptide dimersFiled 1995·Granted Jun 16, 1998·288 cites·9 claims
- 0493US6750325B1CD3 specific recombinant antibodyCELLTECH R&D LTD·Filed 1999·Granted Jun 15, 2004·118 cites·9 claims
- 0593US6491916B1Methods and materials for modulation of the immunosuppresive activity and toxicity of monoclonal antibodiesTOLERANCE THERAPEUTICS INC·Filed 1994·Granted Dec 10, 2002·152 cites·5 claims
- 0688US7544790B2CDR-grafted anti-tissue factor antibodies and methods of uses there ofCENTOCOR INC·Filed 2006·Granted Jun 9, 2009·7 cites·6 claims
- 0786US7041459B2Analyzing phosphorylated proteinsMONOGRAM BIOSCIENCES INC·Filed 2002·Granted May 9, 2006·31 cites·22 claims
- 0885US7235380B1CDR-grafted anti-tissue factor antibodies and methods of use thereofORTHO MCNEIL PHARM INC·Filed 2002·Granted Jun 26, 2007·12 cites·16 claims
- 0969US7777018B2CDR-grafted anti-tissue factor antibodies and methods of use thereofCENTOCOR INC·Filed 2007·Granted Aug 17, 2010·0 cites·3 claims
- 1062US8846013B2Topical application of 1-hydroxyl-3,5-BIS(4′hydroxy styryl)benzeneKAUR SIMARNA·Filed 2012·Granted Sep 30, 2014·0 cites·8 claims
- 1162US4952561ACardiac atrial peptidesMERCK & CO INC·Filed 1985·Granted Aug 28, 1990·11 cites·6 claims
- 1259US2003108548A1Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodiesFiled 2002·Application pending·0 cites
- 1356US2010298544A1Cdr-grafted anti-tissue factor antibodies and methods of use thereofJOLIFFE LINDA K·Filed 2010·Application pending·0 cites
- 1453US2006292142A1Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodiesBLUESTONE JEFFREY A·Filed 2006·Application pending·0 cites
- 1552US2003212079A14-pyrimidinamine derivatives, pharmaceutical compositions and related methodsFiled 2003·Application pending·0 cites
- 1652US2004006094A14-pyrimidinamine derivatives, pharmaceutical compositions and related methodsFiled 2003·Application pending·0 cites
- 1751US2014005275A1Topical application of 1-hydroxyl 3,5-bis(4'hydroxyl styryl)benzeneKAUR SIMARNA·Filed 2012·Application pending·0 cites
- 1850US2006002933A1Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodiesBLUESTONE JEFFREY A·Filed 2005·Application pending·0 cites
- 1948US2007266449A1Generation of animal modelsZIVIN ROBERT A·Filed 2007·Application pending·0 cites
- 2048US2004115614A1Electrophysiology assay methodsFiled 2003·Application pending·0 cites
- 2148US2003008883A14-Pyrimidinamine derivatives, pharmaceutical compositions and related methodsFiled 2001·Application pending·0 cites
- 2247US2003225085A12-pyridinamine compositions and related methodsFiled 2003·Application pending·0 cites
- 2344US2005203092A14-Pyrimidinamine derivatives, pharmaceutical compositions and related methodsFiled 2004·Application pending·0 cites
- 2443US2002198219A12-pyridinamine compositions and related methodsFiled 2001·Application pending·0 cites
- 2542US2005244859A1Cell based assayORTHO MCNEIL PHARM INC·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →